Super Pulsed Laser Therapy Technology Found Effective Treating Critically Ill COVID-19 Patients

After completing a clinical trial evaluating its super pulsed laser therapy technology to improve respiratory function in critically ill COVID-19 patients, medical device manufacturer Multi Radiance Medical (MRM) announced it is preparing to apply for emergency use authorization with the US Food and Drug Administration.

The triple-blind, placebo-controlled clinical trial results show that MRM super pulsed laser therapy decreased invasive intubation time/need by 18% overall, and decreased mechanical ventilation time/need overall by 23%.

“Increased thickness of the diaphragm has been associated with improved inspiratory function and increased vital capacity over time,” stated Dr. Ernesto Leal-Junior, MRM Lead Researcher, in a press release. “This is the first clinical evidence that super pulsed laser therapy can significantly improve symptoms of the critically ill.”